Edition:
India

Harbin Pharmaceutical Swings To H1 Net Loss At 42.3 Million Yuan


Friday, 30 Aug 2019 

Aug 30 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS H1 NET LOSS AT 42.3 MILLION YUAN ($5.96 million) VERSUS NET PROFIT OF 363.0 MILLION YUAN YEAR EARLIER. 

Company Quote